Part two of the whitepaper begins with predictions for how healthcare may look in 2034, mainly focused around the development of 3D printing. The whitepaper forecasts that 3D printing for medical devices and medications will eliminate generic drugs, personalized and electronic distribution of drugs and localized “print centers” serving a certain geographic area.
These future projections will impact how providers, distributors and manufacturers will provide their services. The whitepaper says providers will have to start focusing on inventory utilization and optimization, distributors should start looking at a chemical supply chain and manufacturers need to look at vertical integration and localized print centers.
Read the full whitepaper here.
More Articles on the Future of Healthcare:
Trends for the Future of Healthcare Quality
Healthcare in 2014: 3 CEOs Discuss Key Priorities for the Year Ahead
Survey: Hospital CEOs Expect 12% Reduction to Operating Expenses by 2020
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
